Details for New Drug Application (NDA): 088303
✉ Email this page to a colleague
NDA 088303 describes ELIXOMIN, which is a drug marketed by Cenci and is included in one NDA. Additional details are available on the ELIXOMIN profile page.
The generic ingredient in ELIXOMIN is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in ELIXOMIN is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 088303
| Tradename: | ELIXOMIN |
| Applicant: | Cenci |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088303
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | ELIXIR;ORAL | Strength | 80MG/15ML | ||||
| Approval Date: | Jan 25, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
